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ABSTRACT
Objective This meta- review aims to discuss the 
methodological, research and practical applications 
of tools that assess the measurement properties of 
instruments evaluating health- related quality of life 
(HRQoL) that have been reported in systematic reviews.
Design Meta- review.
Methods Electronic search from January 2008 to May 
2020 was carried out on PubMed, CINAHL, PsycINFO, 
SCOPUS, WoS, Consensus- based Standards for the 
selection of health Measurement Instruments (COSMIN) 
database, Google Scholar and ProQuest Dissertations and 
Theses.
Results A total of 246 systematic reviews were assessed. 
Concerning the quality of the review process, some 
methodological shortcomings were found, such as poor 
compliance with reporting or methodological guidelines. 
Regarding the procedures to assess the quality of 
measurement properties, 164 (66.6%) of reviewers applied 
one tool at least. Tool format and structure differed across 
standards or scientific traditions (ie, psychology, medicine 
and economics), but most assess both measurement 
properties and the usability of instruments. As far as 
the results and conclusions of systematic reviews are 
concerned, only 68 (27.5%) linked the intended use of 
the instrument to specific measurement properties (eg, 
evaluative use to responsiveness).
Conclusions The reporting and methodological 
quality of reviews have increased over time, but there 
is still room for improvement regarding adherence to 
guidelines. The COSMIN would be the most widespread 
and comprehensive tool to assess both the risk of bias 
of primary studies, and the measurement properties of 
HRQoL instruments for evaluative purposes. Our analysis 
of other assessment tools and measurement standards 
can serve as a starting point for future lines of work on the 
COSMIN tool, such as considering a more comprehensive 
evaluation of feasibility, including burden and fairness; 
expanding its scope for measurement instruments 
with a different use than evaluative; and improving its 
assessment of the risk of bias of primary studies.
PROSPERO registration number CRD42017065232.
INTRODUCTION
The systematic reviews of measurement prop-
erties critically appraise the content and 
measurement properties of all instruments 
that assess a certain construct of interest in 
a specific study population.1 These system-
atic reviews provide both a comprehensive 
overview of the measurement properties of 
health instruments and supportive evidence 
for the selection of instruments for a specific 
purpose (eg, research, clinical practice, 
predictive).2 3 In this type of systematic 
review, different authors have evaluated not 
only the methodological quality of their key 
phases—namely the search strategy, the bias 
risk assessment of the primary studies and 
the data synthesis—but also whether the 
measurement properties of the health status 
instruments have been appraised with stan-
dardised procedures or tools during the data 
extraction phase.1 2 4 5 However, depending 
on the measurement standards on which 
these tools were developed, the approach 
to analyse the measurement properties of 
instruments may vary.6 This could lead to 
different conclusions and recommendations, 
in spite of the effort undertaken by the inter-
national Society for Quality of Life Research 
to set consensus- based minimum standards.7 
Besides, according to Rosenkoetter and Tate,6 
Strengths and limitations of this study
 ► The search strategy has been designed to be com-
prehensive, following the Peer Review of Electronic 
Search Strategies guidelines including specific fil-
ters for finding studies on psychometric properties 
of measurement instruments.
 ► A total of 246 systematic reviews were included and, 
to our knowledge, this meta- review provides the 
broadest overview of the most common tools used 
to assess measurement properties of health- related 
quality of life instruments and their relationship with 
measurement standards, scientific traditions and 
the intended use of the measures.
 ► Some of the included systematic reviews poorly 
reported the review process, outcomes and conclu-
sions, and this fact may have led to the loss of some 
data.
 ► Inclusion of studies published in English only may 
have led to language bias.
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the assessment tools commonly used by clinicians and 
researchers to select the appropriate outcome measures 
for specific purposes show a variety of forms and cover 
a mix of standards related to reporting, methodological 
quality and statistical outcome quality.
The aims of this present meta- review are to: (1) identify 
systematic reviews assessing the measurement properties 
of health- related quality of life (HRQoL) instruments; (2) 
identify the main tools applied to assess their measure-
ment properties; (3) describe the contents of the applied 
tools (validity, reliability, feasibility, etc); (4) identify the 
measurement standards on which these tools were devel-
oped or conform to, comparing their similarities and 
differences and (5) appraise how authors of these system-
atic reviews include the assessment of the measurement 
quality in their results and conclusions, that is, to what 
extent conclusions depend on the results of the eval-
uation of the measurement properties, as well as their 
relationship, if any, with the intended use of the HRQoL 
instrument (eg, evaluative).
METHODS
The protocol of this review8 was prospectively registered. 
We conducted this meta- review following the Preferred 
Reporting Items for Systematic Reviews and Meta- Analyses 
guidelines (PRISMA).9 10
Search strategy
A systematic search was performed in PubMed, US 
National Library of Medicine, by National Center for 
Biotechnology Information (NCBI); CINAHL, Cumula-
tive Index to Nursing and Allied Health Literature, by 
EBSCOhost; PsycINFO, Psychological Information, by 
APA PsycNET; SCOPUS by Elsevier; WoS, Web of Science 
CORE, by Thomson Reuters; Consensus- based Standards 
for the selection of Health Measurement Instruments 
database, by COSMIN Initiative (http://www. cosmin. 
nl/); and Google Scholar (up to 400 links). ProQuest 
Dissertations and Theses Global was used for searching 
grey literature, and search alerts in all databases were 
set. The search strategy followed the Peer Review of Elec-
tronic Search Strategies guidelines recommendations,11 12 
and consisted of three filters composed of search terms 
for the following: (1) systematic review methodology; 
(2) HRQoL instruments and (3) measurement proper-
ties. The latter filter was developed by the Vrije Univer-
sity Medical Center for finding studies on measurement 
properties of measurement instruments.13 All filters were 
adapted for all databases. The searches were completed in 
May 2020. Restrictions by language (English) and publi-
cation date (from January 2008) were applied (see online 
supplementary file 1 for search strings for all databases).
Inclusion criteria
Systematic reviews specifically aiming to report or to 
assess the measurement properties of instruments evalu-
ating the quality of life within the context of health and 
disease14 were included. Systematic reviews were required 
to include the full results report, and detailed informa-
tion about the procedures used to assess the measure-
ment properties.
Exclusion criteria
Systematic reviews exclusively focused on evaluating 
clinical interventions were excluded. Systematic reviews 
specifically focused on assessing patient- reported 
outcomes measures (PROMs) other than HRQoL for 
specific diseases, clinical conditions or populations, were 
excluded. Systematic reviews that did not report full infor-
mation about the procedures to assess the measurement 
properties were also excluded (eg, conference abstracts).
Study screening
References identified by the search strategy were entered 
to Mendeley reference management software, and dupli-
cates were removed. Titles and abstracts were screened 
independently by two reviewers (SL and JV). When deci-
sions were unable to be made from title and abstract 
alone, the full paper was retrieved. Full- text inclusion 
criteria were checked independently by two reviewers (SL 
and JV). Discrepancies during the process were resolved 
through discussion (with independent reviews of J- ML 
and CV when necessary).
Data extraction
Extracted information of each selected systematic review 
and meta- analysis included general information such as 
author, year and quality of review process of systematic 
reviews (eg, protocol registration, reporting guidelines 
and use of flow chart). Information concerning the main 
identified tools applied to assess the measurement prop-
erties of HRQoL instruments included the title, intended 
use, number of items, response categories, instrument 
assessment criteria and measurement properties assessed. 
Information on how authors included the assessment of 
the quality of HRQoL in their results and conclusions was 
also extracted. Authors of eligible studies were contacted 
to provide missing or additional data when necessary.
Study aim
To examine the methodological, research and practical 
applications of the reported tools in systematic reviews 
that assess the measurement properties of instruments 
evaluating quality of life within the context of health and 
disease, that is, HRQoL.
RESULTS
Search results
Figure 1 shows the results of the search strategy, reported 
according to the PRISMA flow diagram. A total of 4320 
references were identified through database searches. 
After removing duplicates, 3055 titles and abstracts were 
screened. After the assessment of 525 full- text docu-
ments for eligibility, a total of 246 systematic reviews were 
included in the qualitative analysis. These systematic 
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reviews covered a wide range of HRQoL instruments, 
both generic and disease specific. A total of 24 (9.8 %) 
of the systematic reviews assessed the quality of one 
measurement property only, such as the conceptual and 
measurement model or the content validity (see online 
supplementary file S2 for characteristics and references 
of studies).
Reporting and methodological quality of the studies
Table 1 shows the reporting and methodological quality 
of systematic reviews. Findings showed that 27 (10.9%) of 
the reports registered the protocol prospectively, a figure 
that raised to 20.8% when considering the reports from 
2014 onwards; 78 (31.7%) followed reporting guidelines 
such as PRISMA (50.8% the last 6 years); 42 (17.0% since 
2008; 23.8% for the last 6 years) assessed the reporting 
and/or the methodological quality of primary studies 
using recommended guides, such as Standards for the 
Reporting of Diagnostic Accuracy Studies and Quality 
Assessment of Diagnostic Accuracy Studies, respectively; 
238 (96.7 %) reported the search strategy; 116 (47.41%) 
reported the detailed syntax for one database at least; 
134 (54.4%) made the article selection by two or more 
independent reviewers; 166 (67.5%) used a flow chart 
to report search outcomes and 132 (53.7%) stated the 
funding. These last percentages slightly increased when 
reducing the time frame to the last 6 years.
Assessment of measurement properties of HRQoL instruments
Assessment procedures of measurement properties 
varied considerably. A total of 164 (66.6%) out of 246 
systematic reviews applied one tool at least, that is, a 
published and well- accepted list of criteria, to rate the 
evidence on measurement properties of instruments; 
41 (16.6%) applied their own author’s criteria only; 30 
(12.2%) followed literature recommendations included 
in very highly circulated books or papers only, and 14 
(5.7%) used an ad hoc checklist of criteria only. A total 
of 98 (39.8%) systematic reviews did combine different 
Figure 1 PRISMA flow chart. Flow diagram for search results (from Moher et al9). COSMIN, Consensus- based Standards for 
the selection of health Measurement Instruments; HRQOL, health- related quality of life; PRISMA, Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses.
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procedures. Most usual combinations were the use of two 
tools or one tool and literature recommendations.
Tools to assess measurement properties of HRQoL instruments
The first 12 columns of table 2 present the characteris-
tics for the identified tools used to assess measurement 
properties using the last update we are aware of. Tools 
are reported in order of frequency of use, as pointed 
out in the last row of the table: (1) ‘COSMIN’, COSMIN 
initiative15 16; (2) ‘Quality Criteria for Measurement 
Properties’, Terwee et al17; (3) ‘Attributes and Criteria 
to assess Health Status and Quality of Life Instruments’, 
Scientific Advisory Committee Medical Outcomes Trust 
(SACMOT)18 19; (4) ‘Health Status Measures in Economic 
Evaluation’, Brazier et al20 21; (5) ‘Guidance for Industry 
PROMs’, Food and Drug Administration (FDA)22 23; (6) 
‘Evaluating Patient- based Outcomes Measures for use 
in clinical trials’, Fitzpatrick et al24 (also known as Fitz-
patrick’s criteria); (7) ‘International Classification of 
Functioning’ and ‘International Classification of Func-
tioning for Children and Youth’, WHO25; (8) ‘Evaluating 
Measures of Patient- Reported Outcomes (EMPRO)’, 
Spanish Cooperative Investigation Network for Health 
and Health Service Outcomes Research26; (9) ‘Spinal 
Cord Injury Criteria’, Spinal Cord Injury Rehabilitation 
Evidence27 28; (10) ‘Criteria for Assessing the Tools of 
Disability Outcomes Research’, Andresen29 (also known 
as Andresen’s tool); (11) ‘CanChild Outcomes Measures’, 
CanChild Center for Childhood Disability Research30 
and (12) ‘Outcomes Measures in Rheumatology Clin-
ical Trials (OMERACT)’, OMERACT initiative.31 Table 2 
also includes a final column showing the characteristics 
of Testing Standards by American Educational Research 
Association, American Psychological Association and 
National Council on Measurement in Education32 33 
(hereinafter ‘Testing Standards’) initially published in 
1954 and regularly updated every decade using consensus 
based procedures. The Testing Standards are the source 
of most of the technical vocabulary for measurement 
Table 1 Reporting and methodological quality of studies
2008–2020 2014–2020
N % N %
Protocol registered prospectively
 ► Yes, PROSPERO 27 10.9 26 20.5
 ► No registered 219 89.1 100 79.3
Standards of systematic review reporting and/or quality 
assessment
 ► Yes (AMSTAR, PRISMA, 
QUOROM…)
78 31.7 64 50.8
 ► No 168 68.3 62 49.2
Standards to assess reporting and/or quality assessment of 
primary studies
 ► Yes (QUADAS, STARD…) 42 17.0 30 23.8
 ► No 204 83.0 96 76.2
No of databases searched
 ► 1–3 96 39.1 50 39.6
 ► 4–6 107 43.4 61 48.4
 ► 7–9 22 8.9 8 6.3
 ► ≥10 18 7.3 6 4.7
 ► Not reported 3 1.2 1 0.8
Other sources
 ► Official websites/internet 25 10.1 7 5.5
 ► Virtual libraries 24 9.7 12 9.4
 ► Google/google scholar 25 10.1 14 11.0
 ► Scientific journals/thesis 6 2.4 2 1.6
Search strategy
Terms, databases, time period
 ► Yes 238 96.7 123 97.6
 ► No 8 3.3 3 2.4
Search syntax
 ► Detailed syntax reported 
(Truncations, Booleans…)
115 46.7 79 62.7
 ► Syntax not reported or 
not detailed enough to be 
replicable
125 50.8 46 36.5
 ► Supplementary file under 
request (not available)
5 2.1 1 0.8
Inclusion/exclusion selection criteria
 ► Reported and well- defined 229 93.1 122 96.8
 ► Not reported or not clearly 
stated
17 6.9 4 3.2
Article selection
 ► By two or more independent 
reviewers
134 54.4 87 69.0
 ► Not reported or not clearly 
stated
112 45.6 39 31.0
Flow chart
 ► Yes 166 67.5 108 85.7
Continued
2008–2020 2014–2020
N % N %
 ► No 80 32.5 18 14.1
Funding
 ► Reported 132 53.7 69 54.8
 ► Not reported or not clearly 
stated
114 46.3 57 45.2
Total 246 100 126 100
%, percentage; AMSTAR, assessment of multiple systematic 
reviews; n, frequency; PRISMA, Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses; PROSPERO, Prospective 
Register of Systematic Reviews; QUADAS, Quality Assessment 
of Diagnostic Accuracy Studies; QUOROM, quality of reporting of 
meta- analysis; STARD, Standards for the Reporting of Diagnostic 
Accuracy Studies.
Table 1 Continued
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properties in HRQoL instruments, therefore, they will be 
used as a reference to compare the twelve identified tools. 
In fact, these standards have already been recommended 
to establish a unified approach to validity and reliability 
of results derived from psychometric instruments in clin-
ical medicine, research and education.34
Different methodologies were used to develop the tools. 
The expert panel consensus and the literature review 
were the most usual methods, led by steering committees 
or staff/working groups. The format and structure of 
these tools also vary. Whereas seven of them were itemised 
to allow the assignment of quality scores, the other six 
took the form of standards or guidelines. Tools with an 
itemised structure were the COSMIN, Quality Criteria for 
Measurement Properties, EMPRO, SCI Criteria, Criteria 
for Assessing the Tools of Disability Outcomes Research 
(Andresen’s tool), CanChild Outcomes Measures and 
OMERACT.
Among all measurement properties considered in 
Testing Standards, 11 out of the 12 tools recommended 
to assess the conceptual and measurement model; 
content, structural, convergent, discriminant, concur-
rent and predictive validity; responsiveness or sensitivity 
to change; and internal consistency, test–retest and inter- 
rater reliability. However, the approach to analyse these 
measurement properties varied, with examples found 
in construct validity, criterion validity and reliability. 
Depending on the tool, the validity of the construct 
can be evaluated either by hypothesis confirmation in 
general (eg, COSMIN or EMPRO), or by specific hypoth-
esis based on correlations with other measures, that is, 
convergent and discriminant validity (eg, Andresen’s 
tool). Criterion validity can be assessed either exclu-
sively by calculating the correlation coefficient with a 
gold standard (eg, CanChild Outcomes Measures) or by 
obtaining variously correlation, specificity and sensitivity 
or predictive values (eg, FDA). Reliability can be anal-
ysed either by test retest reliability, inter- rater reliability 
and internal consistency (eg, FDA), or only by test retest 
and inter- rater agreement (eg, Economic evaluation). 
Despite the Testing Standards recommendations, just 
one tool includes additional criteria to assess consequen-
tial validity (SCI), and four assess fairness (eg, accessible 
forms for subjects with vision impairment or for specific 
populations) (SACMOT, FDA, SCI and Andresen’s tool). 
None of them includes criteria to assess the validity of 
response processes. Other HRQoL instrument character-
istics, such as feasibility (eg, cost of obtaining a sample), 
acceptability (eg, suitability from the patient perspective) 
or burden (eg, the time or effort placed on the admin-
istration of the instrument) are assessed instead. Finally, 
notice that some concepts have changed their place 
over time. The clearest case is evidence regarding cross- 
cultural equivalence, which was treated as an additional 
characteristic of the instruments in most tools released 
before 2014 (eg, EMPRO or SCI), but was considered a 
proper measurement property in the COSMIN’s 2018 
update. It is also considered a measurement property 
in Testing Standards where it is included as a particular 
case of differential item functioning when assessing the 
internal structure of the instruments (see online supple-
mentary file S3 for more details).
Intended uses of instruments and their association to 
measurement properties
Some of the differences between tools can be attributed 
to the fact that they are devoted to the evaluation of 
instruments developed with different intended uses. For 
instance, COSMIN aims at assessing the quality of instru-
ments for an evaluative purpose whereas the Economic 
Evaluation tool aims at the assessment of instruments for 
analytical purposes. Nevertheless, the relation between 
the intended use of the instruments and the measurement 
properties assessed is not usually included in the conclu-
sions of the systematic reviews. Table 3 shows the intended 
use of instruments, based on the framework proposed 
by McDowell et al35 and the association to measurement 
properties that reviewers established in their conclusions. 
The instruments were most frequently used for evalua-
tion (178, 72.3%) and for assessment of impact of disease 
on HRQoL (138, 55.1%), either alone or in conjunction. 
Other purposes were analytic (35, 14.2%), diagnostic (16, 
6.5%), descriptive (4, 1.6%) and predictive (2, 0.8%). 
A total of 6 (2.4%) systematic reviews did not report or 
did not clearly state the intended use of the instruments. 
As far as the assessment and conclusions is concerned, 
only 68 (27.6%) systematic reviews linked the intended 
use of the instrument to measurement properties. The 
most common use was evaluative, generally associated to 
responsiveness, content validity or reliability, for example. 
When the purpose was the assessment of the impact of 
disease on HRQoL, the conceptual and measurement 
model and content validity were usually reported. The 
analytical purpose involved reporting preference- based 
valuation (eg, utility scores) and evidence of agreement, 
and the diagnostic use was linked to known groups 
validity and test–retest reliability. To better understand 
these results, some examples are given. First, the evalu-
ative purpose was associated to responsiveness, we found 
conclusions such as: ‘For use in longitudinal studies or 
clinical practice, where responsiveness is an issue, the 
Minnesota Living with Heart Failure Questionnaire 
and the Chronic Heart Failure Questionnaire would be 
adequate’.36 Second, the intended use was the assessment 
of the impact of disease on HRQoL, the usual association 
was to the measurement model and conclusions resem-
bled this one: ‘None of the RLS specific QOL measures 
appears to have been informed by a conceptual model 
or a conceptual framework. Consequently, none can be 
considered comprehensive in terms of assessing the full 
impact of Rest Legs Syndrome on QOL’.37 Third, an 
example illustrating general conclusions, that is, conclu-
sions that did not associate the intended use of the 
instrument to any specific measurement properties, was 
as follows: ‘None of the available instruments fulfils the 
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psychometric demands of reliability, validity and respon-
siveness to serve as a primary outcome measure in clinical 
trials’.38
DISCUSSION
The present meta- review identified 246 systematic 
reviews assessing measurement properties of HRQoL 
instruments in order to analyse the quality of the review 
process, describe the most used tools to assess measure-
ment properties and examine how reviewers included the 
assessment of the quality of HRQoL in their conclusions.
Reporting and methodological quality of the studies
Findings showed how the reporting and methodological 
quality of systematic reviews has increased over time. Most 
reviewers reported the search strategy, stated the inclu-
sion and exclusion criteria taking the judgement of two 
or more independent reviewers into account and used 
a flow chart to report search outcomes. However, some 
crucial methodological shortcomings were found. Prac-
tices such as registration of the protocol, reporting the 
detailed search syntax for one database at least, adherence 
to reporting guidelines, and assessing the reporting and 
the methodological quality of primary studies were quite 
sparse even in recent years. As Pussegoda et al4 suggested, 
this fact may be related to the percieved time- consuming 
task of using guidelines or to the lack of information 
about the most appropiate tool. According to our data, 
there is still large room for improvement in the assess-
ment of the methodological quality of included studies 
in order to attend to Terwee et al’s warning2 of avoiding 
the risk of presenting biased results, leading to underesti-
mation or overestimation of the quality of an instrument.
Assessment of measurement properties of HRQoL instruments
Assessment procedures of measurement properties of 
HRQoL instruments were diverse. Most of the reviewers 
used at least one tool. Nevertheless, there were reviewers 
that applied their own criteria, followed literature recom-
mendations or applied different ad hoc devised check-
lists. The use of such diverse procedures is noticeable, 
even in recent years, when well- accepted tools to assess 
measurement properties are available.
Our meta- review identified up to twelve tools. Seven of 
them had an itemised structure, offering a comparable 
approach to rate the evidence on measurement proper-
ties. Length and scoring differed, but also the instrument 
assessment criteria. Actually, depending on the tool used, 
the approach to assess properties varied greatly, with 
potentially serious consequences. The fact that a single 
measurement property is or isn’t required can change 
the status of quality of the evidence supporting the same 
measurement instrument. The variety of forms found were 
in concordance to results from related research, which 
also highlighted the complexity with regard to defini-
tions of measurement properties.6 This complexity is also 
reflected in the search filter developed by the COSMIN 
initiative.13 They recommend using three filters that sum 
up more than 100 search terms in order to get sensible 
and specific results. In addition, and also depending on 
the tool used, other characteristics, such as feasibility, 
acceptability and burden were assessed. In spite of the 
diversity, a shared conclusion can be stated as follows: 
because these instruments are to be used in the daily 
practice, their usability should be always balanced with 
other characteristics considered as proper measurement 
Table 3 Intended use of instruments and their association 
to measurement properties
Intended use of instruments 
identified across the systematic 
reviews Frequency % (over 246)
Evaluative (Change scores pre and 
poststudies. Effectiveness of an 
intervention)
178 72.3
Impact of disease on HRQoL (disease 
symptoms, burden…)
138 55.1
Analytic (health policies. Cost- 
effectiveness. Funding)
35 14.2
Diagnostic (Distinguish between 
groups, levels of severity…)
16 6.5
Descriptive (Health measures in 
surveys. Needs of groups of people)
4 1.6
Predictive (Anticipation of future health 
status. Risk factors. Risk profiles)
2 0.8
Intended use is no reported or no 
clearly stated
6 2.4
Conclusions according to the 
intended use of instruments
n % (over 246)
Yes, reviewers made specific 
conclusions
68 27.6
No, reviewers made general 
conclusions
178 72.4
Measurement properties associated 
to the intended use of the 
instrument
n % (Over 68)
Evaluative
Responsiveness/Conceptual and 
Measurement Model/Content validity/
Reliability (internal consistency, 
test retest)/Respondent Burden/
Convergent validity/Cross cultural 
validity
41 60.3
Impact
  Conceptual and Measurement 
Model/Content validity
29 42.6
Analytic
  Preference- based valuation/
agreement
11 16.2
Diagnostic
  Known groups validity/test–retest 7 10.3
Predictive
  Sensivity and specificity 1 1.5
(%), percentage.
HRQoL, health- related quality of life.
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properties.39 40 For instance, an instrument needs to be 
long enough to ensure reliability and construct validity, 
but short enough to ensure the adequate response rate 
and sample size. Otherwise the instrument intended use 
and sustainability will be at hazard.39
The differences between tools and their potentially 
serious consequences on the assessment of the quality of 
the primary studies may be better addressed in the light 
of three considerations: the date of publication, the main 
scientific tradition involved when developing the tools, 
and the intended uses of the instruments under assess-
ment. Some differences can be simply explained by the 
date of publication of the tools. As an example, where 
older tools require specific forms of validity evidence 
related to external variables such as convergent and 
discriminant validity, recent tools incorporate the more 
general view of hypothesis testing. That is, when devel-
oping a new use for an instrument, hypotheses should be 
made regarding the expected relations with other rele-
vant variables in their nomological network and these 
hypotheses and no other should be tested.32 Regarding 
the scientific traditions, the assessment of outcomes is 
a constitutive part of the disciplines of Education and 
Psychology where the Testing Standards come from. In 
these contexts, participation is taken for granted as assess-
ment practices result in high stakes decisions such as, for 
instance, certification or personnel selection. The main 
concern regarding integrity of the instrument purpose 
is its fakeability, which could distort the decision- making 
process, and this would explain the interest in response 
processes in this field.41 42 By contrast, the main objec-
tive in the discipline of Medicine is to provide health-
care services. Evaluation of subjective views of patients 
was a late addition related to the inclusion of HRQoL 
in the accounting of healthcare outcomes, despite the 
instruments assessing the patient experience should be 
acceptable to both patients and clinicians, as Beattie et 
al highlighted.39 Specifically, in the context of disability 
research, the administrative and respondent burden 
requires additional consideration. The administrative 
burden may include the need for a Sign Language inter-
preter, and the respondent burden includes the length of 
the questionnaire, which is especially relevant when using 
HRQoL instruments with cognitively impaired subjects.29 
Balancing the traditional psychometric criteria, the prac-
ticalities of the instruments and patient preferences 
is a generic recommendation for health research, but 
becomes a special obligation for research with people with 
specific needs.29 Moreover, devising test accommodations 
or accessible forms when needed is expected to become a 
required psychometric criterion in the near future, given 
that it has already been included under the title ‘fairness 
in testing’ as a new section next to validity and reliability 
in the chapter of measurement foundations in the most 
recent update of Testing Standards.32
Another criterion is that of economic evaluation, tradi-
tionally embedded in providing quantitative judgements 
able to be integrated into mathematical models such as 
those used in calculating quality- adjusted life years and 
using preference- based methods to obtain their data. 
Due to that, some very popular measurement proper-
ties such as internal structure based on factor analysis 
are not relevant and thus not considered in their tools. 
In this tradition, the main concern regarding the integ-
rity of the instrument purpose is whose values should 
be considered when determining preferences and how 
well the preferences of patients and decision makers are 
likely to conform to the main assumptions of the utility 
models.20 21
Intended uses of instruments and their association to 
measurement properties
In our view, considering in the first place the intended 
use of the HRQoL instrument would help to reconcile 
the different requirements included in each tool. Tools 
for evaluating the measurement quality of instruments 
should be adapted or extended according to the different 
intended uses of these instruments, such as evaluative, 
impact of disease, analytic, diagnostic, descriptive or 
predictive. Notice that depending on the intended use 
of the measure, some domains of validity and reliability 
may be of greater or lesser relevance.6 16 For instance, 
an instrument developed to assess longitudinal changes 
should demonstrate high responsiveness,6 but if used 
for diagnostic purposes, it should be able to distinguish 
among individuals or groups,6 that is, known groups 
validity. Another example is the internal consistency reli-
ability based on interitem relationships that may be not 
relevant for a preference- based instrument but is relevant 
for an instrument based on a unidimensional measure-
ment model. However, our data showed that only a few 
authors established a clear link in their recommenda-
tions between the intended use of the measure and the 
reported evidence of measurement properties. The vast 
field of HRQoL offered a plethora of instruments but, 
as most reviewers did not take the intended use of the 
instrument into account, the overall rating of measure-
ment properties was not consistent and thus the instru-
ment may or may not have been adequate for its intended 
use. Because the evaluation and improvement of quality 
of life is considered a public health priority,14 we strongly 
encourage researchers to assess the quality of measure-
ment properties of HRQoL instruments according to the 
intended use of the measure. Otherwise, there is a serious 
risk of biased results, which could lead to underrating the 
quality and suitability of the instrument.
CONCLUSIONS
The quality of the systematic review process has been 
increasing over time, but it should still improve with 
regard to the prospective registration of protocol, and 
with respect to the adoption of guidelines to improve 
both the methodological and reporting quality of the 
reviews. In the specific context of systematic reviews of 
measurement instruments, enhancing the quality of the 
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process also involves the assessment of measurement 
properties by using a standardised tool. The selection of 
the most suitable tool may be addressed according to the 
coverage of the appraised measurement properties, but 
also according to other important criteria, such as the 
intended use of the HRQoL instruments, the format of 
the tool and whether it assesses both usability (eg, feasi-
bility or burden) and accommodation (or accessible 
forms). First, the assessment methodology should be 
adapted when necessary, establishing the relation between 
the intended use of the HRQoL instruments and the 
measurement properties assessed. Second, to standardise 
the review process, the tool’s format should be itemised 
offering a comparable approach to rate the evidence on 
measurement properties. Those tools that take the form 
of guidelines, such as the SACMOT or the economic eval-
uation would be considerably upgraded if the structure is 
reconverted, since the current format only allows descrip-
tion rather than critical appraisal of the quality of an 
instrument, and furthermore, it complicates comparison 
of results. Lastly, because systematic reviews on measure-
ment properties aim to help professionals to select the best 
instrument for a clinical scenario, the feasibility, patient’s 
preferences, administrator and respondent burden, and 
the accommodations (or accessible forms) should be 
addressed and evaluated. Otherwise the suitability and 
the intended use of instruments might be compromised, 
especially in the context of disability research. Tools iden-
tified in our meta- review that meet most of these criteria 
are the COSMIN, EMPRO, SCI criteria, Andresen’s tool, 
CanChild Outcomes and OMERACT, since all of them 
cover a wide range of measurement properties, offer an 
item structure, and assess the usability of instruments.
Special mention is due to the COSMIN, the most wide-
spread and comprehensive tool to assess measurement 
properties of health instruments designed for an evalu-
ative purpose. The COSMIN standards were developed 
in a Delphy study43 aiming to improve the selection 
of the most appropriate health instrument for a clin-
ical scenario. The most recent version of the COSMIN 
consists of a manual for conducting systematic reviews 
of health instruments, providing different steps with 
respect to the literature search process, the assessment 
of measurement properties and feasibility of instruments, 
and the evaluation of the risk of bias (RoB) of studies 
according to the Cochrane methodology.16 Additionally, 
the COSMIN initiative recently developed a guideline 
exclusively focused on assessing the content validity of 
health instruments, considered the most important prop-
erty to ensure the adequate reflection of the construct 
measured.44 45 In the light of these considerations, we 
strongly recommend the application of the latest version 
of the COSMIN to conduct high- quality systematic reviews 
on measurement properties of health instruments for an 
evaluative purpose, or for other purposes with appro-
priate adaptation.
Despite COSMIN’s many strengths, our analysis of the 
other assessment tools and measurement standards allow 
us to suggest future lines of work on this tool. First, the 
current format of COSMIN is fairly complex, requiring 
high expertise in the field of psychometrics and specific 
training for its proper application. The reporting of the 
inter- rater agreement coefficients when reviewers use the 
last version of COSMIN may provide useful data about 
its reliability. Second, consideration should be given to 
the testing standards recommendation on the inclusion 
of the assessment of fairness (ie, evaluation of accessible 
forms for specific populations). Third, the feasibility 
of the measurement instruments, merely described in 
COSMIN, and their burden, should be properly rated, 
with examples found in EMPRO or Andresen’s tool. 
Fourth, it must be considered that the RoB evaluation of 
studies is itself a productive field of research with a long 
tradition, with specific tools that have been developed for 
different research questions and study designs. Examples 
might be found in the Cochrane Collaboration’s Tool for 
Assessing the Risk of Bias of Clinical Trials,46 the Newcastle 
Ottawa Scale47 for non- randomised studies, or the Quality 
Assessment Tool for Cohort Studies.48 49 From our point 
of view, the COSMIN proposal could also be simplified 
and improved by guiding the reviewers towards the iden-
tification of the most appropriate RoB assessment tools 
instead of developing their own RoB appraisal guidelines, 
taking advantage of knowledge and innovations in that 
field of research.
And last, but not least, improving the quality of system-
atic reviews encompasses researchers, sponsors and 
promoters, but also journals, which should require full 
compliance with reporting and methodological guide-
lines, and the use of assessment tools.
Twitter Jaume Vives @VivesJ_Research and Josep- Maria Losilla @jmlosilla
Contributors All authors meet the criteria recommended by the International 
Committee of Medical Journal Editors, ICMJE. All authors made substantial 
contributions to conception and design, piloted the inclusion criteria and provided 
the direction of the data extraction and analysis. SL drafted the article and JV, CV 
and J- ML critically revised the draft for important intellectual content. All authors 
agreed on the final version.
Funding This work was supported by the Grant PGC2018-100675- B- I00, Spanish 
Ministry of Science, Innovation and Universities (Spain).
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in 
the design, or conduct, or reporting, or dissemination plans of this research.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available on reasonable request. Data are 
available on reasonable request to the authors.
Open access This is an open access article distributed in accordance with 
the Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this work non- 
commercially, and license their derivative works on different terms, provided the 
original work is properly cited, appropriate credit is given, any changes made 
indicated, and the use is non- commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/.
ORCID iD
Sonia Lorente http:// orcid. org/ 0000- 0002- 5494- 3325
Protected by copyright.
 o
n
 August 12, 2020 at FundaciÃƒÂ³ Joan Costa Roma.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-036038 on 11 August 2020. Downloaded from 
10 Lorente S, et al. BMJ Open 2020;10:e036038. doi:10.1136/bmjopen-2019-036038
Open access 
REFERENCES
 1 Mokkink LB, Terwee CB, Stratford PW, et al. Evaluation of the 
methodological quality of systematic reviews of health status 
measurement instruments. Qual Life Res 2009;18:313–33.
 2 Terwee CB, Prinsen CAC, Ricci Garotti MG, et al. The quality 
of systematic reviews of health- related outcome measurement 
instruments. Qual Life Res 2016;25:767–79.
 3 Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for 
systematic reviews of patient- reported outcome measures. Qual Life 
Res 2018;27:1147–57.
 4 Pussegoda K, Turner L, Garritty C, et al. Identifying approaches 
for assessing methodological and reporting quality of systematic 
reviews: a descriptive study. Syst Rev 2017;6:1–12.
 5 Pussegoda K, Turner L, Garritty C, et al. Systematic review 
adherence to methodological or reporting quality. Syst Rev 
2017;6:1–14.
 6 Rosenkoetter U, Tate RL. Assessing features of psychometric 
assessment instruments: a comparison of the COSMIN checklist 
with other critical appraisal tools. Brain Impair 2017:1–16.
 7 Reeve BB, Wyrwich KW, Wu AW, et al. ISOQOL recommends 
minimum standards for patient- reported outcome measures used in 
patient- centered outcomes and comparative effectiveness research. 
Qual Life Res 2013;22:1889–905.
 8 Lorente S, Vives J, Viladrich C, et al. Tools to assess the 
measurement properties of quality of life instruments : a meta- review 
protocol. BMJ Open 2018;8:1–4.
 9 Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for 
systematic reviews and meta- analyses: the PRISMA statement. Ann 
Intern Med 2009;151:264–9.
 10 Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for 
reporting systematic reviews and meta- analyses of studies that 
evaluate health care interventions: explanation and elaboration. Ann 
Intern Med 2009;151:W65–94.
 11 McGowan J, Sampson M, Salzwedel DM, et al. PRESS peer review 
of electronic search strategies: 2015 guideline explanation and 
elaboration (PRESS E&E). Cadth Methods Guidel 2016:40–6.
 12 McGowan J, Sampson M, Salzwedel DM, et al. PRESS peer review 
of electronic search strategies: 2015 guideline statement. J Clin 
Epidemiol 2016;75:40–6.
 13 Terwee CB, Jansma EP, Riphagen II, et al. Development of a 
methodological PubMed search filter for finding studies on 
measurement properties of measurement instruments. Qual Life Res 
2009;18:1115–23.
 14 Secretary’s Advisory Committee on National Health Promotion and 
Disease Prevention Objectives. Health- related quality of life and well- 
being, 2010. Available: https://www. healthypeople. gov/ sites/ default/ 
files/ HRQoLWBFullReport. pdf
 15 Mokkink L, Terwee C, Patrick D, et al. The COSMIN checklist manual, 
2012. Available: http://www. cosmin. nl/ images/ upload/ files/ COSM 
INch eckl istm anualv9. pdf
 16 Mokkink LB, Prinsen C, Patrick D, et al. COSMIN methodology for 
systematic reviews of patient- reported outcome measures (PROMs). 
User manual 2018:1–78.
 17 Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria 
were proposed for measurement properties of health status 
questionnaires. J Clin Epidemiol 2007;60:34–42.
 18 Aaronson N, Alonso J, Burnam A, et al. Assessing health status and 
quality- of- life instruments: attributes and review criteria. Qual Life 
Res 2002;11:193–215.
 19 Lohr KN, Aaronson NK, Alonso J, et al. Evaluating quality- of- life and 
health status instruments: development of scientific review criteria. 
Clin Ther 1996;18:979–92.
 20 Brazier J, Deverill M, Green C. A review of the use of health 
status measures in economic evaluation. Health Technol Assess 
1999;3:1–164.
 21 Brazier J, Ratcliffe J. Measurement and Valuation of Health for 
Economic Evaluation. In: International encyclopedia of public health. 
. Elsevier, 2017: Vol. 4. 586–93.
 22 Department of Health and Human Services. Guidance for industry 
patient- reported outcome measures: use in medical product 
development to support labeling claims: draft guidance. Vol. 20, 
2006.
 23 Department of Health and Human Services. Guidance for industry 
patient- reported outcome measures: use in medical product 
development to support labeling claims, 2009.
 24 Fitzpatrick R, Davey C, Buxton MJ, et al. Evaluating patient- based 
outcome measures for use in clinical trials. Vol. 2, 1998.
 25 World Health Organization. International classification of functioning 
(ICF), 2016. Available: www. who. int/ classifications/ icf/ en/ [Accessed 
6 Feb 2020].
 26 Valderas JM, Ferrer M, Mendívil J, et al. Development of EMPRO: a 
tool for the standardized assessment of patient- reported outcome 
measures. Value Health 2008;11:700–8.
 27 SCIRE. Spinal cord injury rehabilitation evidence. Available: https:// 
scireproject. com
 28 Johnston MV, Graves DE. Towards guidelines for evaluation of 
measures: an introduction with application to spinal cord injury. J 
Spinal Cord Med 2008;31:13–26.
 29 Andresen EM. Criteria for assessing the tools of disability outcomes 
research. Arch Phys Med Rehabil 2000;81:S15–20.
 30 Law M. Outcome measures rating form guidelines, 2004. Available: 
https://www. canchild. ca/ system/ tenon/ assets/ attachments/ 000/ 000/ 
371/ original/ measguid. pdf
 31 OMERACT. Instrument selection for core outcome measurement 
sets. OMERACT Handbook, 2019. https:// omeracthandbook. org/ 
handbook
 32 APA, AERA, NCME. Standards for educational and psychological 
testing. American Educational Research Association, 2014.
 33 APA, AERA, NCME. Standards for educational and psychological 
testing. American Educational Research Association, 1999.
 34 Cook DA, Beckman TJ. Current concepts in validity and reliability 
for psychometric instruments: theory and application. Am J Med 
2006;119:166.e7–166.e16.
 35 McDowell I, Spasoff RA, Kristjansson B. On the classification 
of population health measurements. Am J Public Health 
2004;94:388–93.
 36 Garin O, Ferrer M, Pont A, et al. Disease- specific health- related 
quality of life questionnaires for heart failure: a systematic review with 
meta- analyses. Qual Life Res 2009;18:71–85.
 37 Speight J, Howarth A. Quality of life in restless legs syndrome: a 
systematic review of clinical trials and a critical review of instruments. 
Patient 2010;3:185–203.
 38 Chassany O, Holtmann G, Malagelada J, et al. Systematic 
review: health- related quality of life (HRQOL) questionnaires in 
gastro- oesophageal reflux disease. Aliment Pharmacol Ther 
2008;27:1053–70.
 39 Beattie M, Lauder W, Atherton I, et al. Instruments to measure patient 
experience of health care quality in hospitals: a systematic review 
protocol. Syst Rev 2014;3:4.
 40 Lorente S, Losilla J- M, Vives J. Instruments to assess patient 
comfort during hospitalization: a psychometric review. J Adv Nurs 
2018;74:1001–15.
 41 Ferrando PJ, Anguiano- Carrasco C. A structural model- based 
optimal Person- Fit procedure for identifying Faking. Educ Psychol 
Meas 2013;73:173–90.
 42 Ferrando PJ, Anguiano- Carrasco C. A structural equation model at 
the individual and group level for assessing faking- related change. 
Struct Equ Model 2011;18:91–109.
 43 Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist 
for assessing the methodological quality of studies on measurement 
properties of health status measurement instruments: an 
international Delphi study. Qual Life Res 2010;19:539–49.
 44 Terwee CB, Prinsen CA, Chiarotto A. COSMIN methodology for 
assessing the content validity of PROMs: user manual. Vol. 120, 
2018.
 45 Terwee CB, Prinsen CAC, Chiarotto A, et al. COSMIN methodology 
for evaluating the content validity of patient- reported outcome 
measures: a Delphi study. Qual Life Res 2018;27:1159–70.
 46 Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane 
collaboration's tool for assessing risk of bias in randomised trials. 
BMJ 2011;343:d5928–9.
 47 Wells G, Shea B, O'Connell D, et al. The Newcastle- Otawa scale 
(NOS) for assessing the quality of nonrandomised studies in 
meta- analyses, 2000. Available: www. ohri. ca/ programs/ clinical_ 
epidemiology/ oxford. asp
 48 Jarde A, Losilla J- M, Vives J, et al. Q- Coh: A tool to screen the 
methodological quality of cohort studies in systematic reviews and 
meta- analyses. Int J Clin Heal Psychol 2013;13:138–46.
 49 Jarde A, Losilla J- M, Oliveras I. Quality assssment tool for cohort 
studies (Q- COH II) user’s manual, 2014: 1–13.
Protected by copyright.
 o
n
 August 12, 2020 at FundaciÃƒÂ³ Joan Costa Roma.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-036038 on 11 August 2020. Downloaded from 
